Sangamo Therapeutics (SGMOQ) Change in Acquisitions & Divestments (2010 - 2024)

Sangamo Therapeutics' Change in Acquisitions & Divestments history runs 15 years deep, the most recent figure standing at -$33.6 million for Q3 2024.

• In Q3 2024, Change in Acquisitions & Divestments changed N/A year-over-year to -$33.6 million; the TTM figure through Jun 2025 stood at -$33.6 million (down 161.73% YoY), while the FY2024 annual figure was $1.1 million, down 94.38% from the prior year.
• Change in Acquisitions & Divestments for Q3 2024 stood at -$33.6 million, down from $34.7 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $314.6 million in Q4 2020, with the low at -$252.7 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $84.4 million (2022), against an average of $58.8 million.
• The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments jumped 222.84% in 2021, then tumbled 370.98% in 2022.
• Sangamo Therapeutics' Change in Acquisitions & Divestments stood at $314.6 million in 2020, then sank by 70.35% to $93.3 million in 2021, then sank by 370.98% to -$252.7 million in 2022, then soared by 107.81% to $19.7 million in 2023, then sank by 270.34% to -$33.6 million in 2024.
• Business Quant data shows SGMOQ's Change in Acquisitions & Divestments at -$33.6 million in Q3 2024, $34.7 million in Q1 2024, and $19.7 million in Q4 2023.